Non-Profit, Valeos, Teams with Oracle to Advance the U.S. Organ Transplant Industry and Improve Patient Access and Outcomes
- S&P 500, Nasdaq notch biggest weekly losses since March
- S&P 500 could end the year over 10% higher from here - Piper Sandler
- Citi says Meta shares to rally in near term on share gains, upcoming AI event
- Ads are coming to Amazon Prime Video next year; Stock pops
- 'Sell the last rate hike' strategy is in action, stocks could fall further - BofA's Hartnett
Valeos announces collaboration with technology powerhouse, Oracle, to unite stakeholders in the organ transplant ecosystem through data, technology, and collaboration to drive better patient outcomes.
"During my emergency heart transplant journey in 2021, our family experienced firsthand that the transplant system needs vast improvements to better serve patients and donors," said
Oracle has been a design partner for Valeos, volunteering its deep expertise in healthcare and data management as the company looks to disrupt the transplant industry.
To celebrate this collaboration and progress towards healthcare modernization, Tristan and his wife
Valeos' collaboration with Oracle Health marks a significant milestone to uniting transplant stakeholders through aggregated and longitudinal patient data. Oracle is providing Valeos access to industry-leading expertise in electronic health records (EHRs), complex integrations, cloud infrastructure, security, and compliance.
During the keynote address, Oracle will present a powerful video highlighting Tristan's and his family's journey as a transplant recipient and the work Valeos is doing to solve transplant's hardest problems.
"The drive Tristan and Jordan have to build Valeos and reimagine the transplant patient experience is extraordinary," said
For more information, visit https://valeos.org/.
Visit https://www.oracle.com/oracle-health-conference/ to learn more and register.
Valeos Transplant Society is a patient-founded, patient-centric 501(c)(3) tax-exempt nonprofit based in
With more than 100,000 Americans awaiting transplant, the
Oracle offers integrated suites of applications plus secure, autonomous infrastructure in the Oracle Cloud. For more information about Oracle (NYSE: ORCL), please visit us at www.oracle.com.
Oracle, Java, MySQL and NetSuite are registered trademarks of Oracle Corporation. NetSuite was the first cloud company--ushering in the new era of cloud computing.
View original content to download multimedia:https://www.prnewswire.com/news-releases/non-profit-valeos-teams-with-oracle-to-advance-the-us-organ-transplant-industry-and-improve-patient-access-and-outcomes-301931137.html
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oracle (ORCL) Shares Edge Lower with Analyst Meeting Underway
- IDACORP Increases Common Stock Dividend 5.1%
- Concord Medical Reports Financial Results for the First Half of 2023
Create E-mail Alert Related CategoriesPRNewswire, Press Releases
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!